newsfilter
← Latest News
GlobeNewswire·

Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring

Discontinues Development of Cibotercept in PAH Announces Corporate Restructuring to Align Operations with Ongoing Strategic Priorities LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc.